HSIOIRS PROGRAM FINAL GR

Page 34 - HSIOIRS PROGRAM FINAL GR

P. 34

Clareon. PanOptix. Trifocal IOL
NO ONE
DREAMS
OF SILVER
PanOptix® is the most implanted trifocal IOL worldwide and delivers an exceptional high-quality visual experience from far
to near, with 99% patient satisfaction.1-4*
20/20 VISION AT ALL >9/10 PATIENTS ARE NATURAL FOCAL DISTANCES4,† SPECTACLE INDEPENDENT5 POINT OF 60CM4,6
Ιατροτεχνολογικό προϊόν CE 0123
Παρακαλούμε διαβάστε προσεκτικά τις οδηγίες χρήσης του προϊόντος πριν τη χρήση του για περισσότερες λεπτομέρειες ως προς τις ενδείξεις, αντενδείξεις και προφυλάξεις. Τα εμπορικά σήματα αποτελούν ιδιοκτησία των αντίστοιχων κατόχων τους
Για περισσότερες πληροφορίες απευθυνθείτε στην ΑΛΚΟΝ ΛΑΜΠΟΡΑΤΟΡΙΣ ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΑΕΒΕ, τηλ επικοινωνίας +30 210 6878300.
*Based on global Clareon® PanOptix® and AcrySof® PanOptix® unit sales 2021-2022
†Pooled binocular defocus curve data from six individual studies. Snellen VA was converted from logMAR VA. A Snellen notation of 20/20^-2 or better indicates a logMAR VA of 0.04 or better, which means ≥3 5 ETDRS chart letters in the line were identified correctly.
1. Market Scope 2022 IOL Market Report
2. Alcon data on file, REF-18881, 2022
3. Clareon® PanOptix® Directions for Use_09/2021
4. Modi et al. Visual and Patient-Reported Outcomes of a Diffractive Trifocal Intraocular Lens Compared with Those of a Monofocal Intraocular Lens. 2020 Sep 28;S0161-6420(20)30677-1
5. Zhu D. et al., Rate of Complete Spectacle Independence with a Trifocal Intraocular Lens: A Systematic Literature Review and Meta-Analysis, Journal of Ophthalmology and Therapy, 02/2023
6. Lwowski C, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive EDOF and trifocal intraocular lenses. J Cataract Refract Surg 2021 Aug 18. doi: 10.1097/j.jcrs.0000000000000780
©2023 Alcon Inc. 11/23 GR-CPO-2300003

32 33 34 35 36